Philipp Spycher, Araris CEO
Promising better linker tech to ADC field, Araris has 'very, very ambitious' plans for the clinic
A couple months after raising CHF 2.5 million ($2.76 million) in initial seed funding, one-year-old Araris Biotech is topping off the round with another CHF …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
